342O Zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+ metastatic pancreatic adenocarcinoma (mPAC): phase II GLEAM study

Annals of Oncology 2026 Open access

Read full text
Authors: W. Park, L. Shen, M.P. Ducreux, S. Mitsunaga, G. Roth, B. Shen, R. Garcia-Carbonero, C-P. Li, S.C. Oh, C. Fountzilas, J. Furuse, E.G. Chiorean
+8 more M. Pishvaian, P. Bhattacharya, F. Kunieda, M. Matsangou, Y. Zhao, J. Hill, A. Guerrero, E.M. O'Reilly
DOI: 10.1016/j.annonc.2026.05.383
Cited by: 1

Fields of Study & Subjects

Barrier Structure and Function Studies Pancreatic and Hepatic Oncology Research Cell Adhesion Molecules Research

Publication details

Journal / source
Annals of Oncology
Publisher
Elsevier BV
Volume
37
Pages
S124–S125
Publication date
1 July 2026
Language
EN